ATR Stock Analysis: Buy, Sell, or Hold?
ATR - AptarGroup, Inc.
$114.67
-3.32 (-2.81%)
▼
5d:
-5.22%
30d:
-10.62%
90d:
-19.57%
HOLD
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Get Alerted When ATR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ATR shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$202.19
Based on 8.9% avg growth
INTRINSIC VALUE TODAY
$125.54
8.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATR is currently trading at $114.67, which is considered oversold relative to its 30-day fair value range of $120.03 to $129.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.3) compared to its historical average (21.1). Remarkably, the market is currently pricing in an annual earnings decline of 4.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATR is showing sideways momentum. The price is currently testing key support at $114.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $163.29 (+42.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ATR is showing sideways momentum. The price is currently testing key support at $114.47. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ATR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $163.29 (+42.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$120.03 -
$129.66
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
Protect Your Profits
Holding ATR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.4% below Wall St target ($163.29)
- CAUTION: Recommendation downgraded due to -5.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$120.03 -
$129.66
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.20
(3.7%)
Support & Resistance Levels
Support Level
$114.47
Resistance Level
$126.47
Current Trend
Sideways
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.28
Wall Street Target
$163.29
(+42.4%)
Revenue Growth (YoY)
10.8%
Earnings Growth (YoY)
-4.3%
Profit Margin
10.0%
Valuation Discount vs History
-4.7% cheaper
PE vs Historical
18.3 vs 21.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.7%
(market-implied from PE analysis)
1-Year Target
$109.28
(-5%)
2-Year Target
$104.14
(-9%)
3-Year Target
$99.25
(-13%)
3-Yr Target (if PE normalizes)
(PE: 18→21)
$114.55
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 13.8%)
$204.07
(+78%)
Base:
(SPY PE: 18.3, Growth: 13.8%)
$169.04
(+47%)
Bear:
(PE: 15.5, Growth: 13.8%)
$143.68
(+25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (18x PE) as earnings recover.
Trailing PE: 20.20 | Current EPS (TTM): $5.84
Bull Case
$139.40
(+22%)
Analyst growth 7.4%, PE expands to 22.2
Base Case
$126.73
(+11%)
Market implied 7.4%, PE stable at 20.2
Bear Case
$80.23
(-30%)
Severe decline -20.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.3 to 21.1
Stabilization Target:
$132.35
(+15.4%)
PE Expansion Potential:
+15.4%
Share & Embed Analysis
Last updated: May 15, 2026 7:32 PM ET
Data refreshes hourly during market hours. Next update: 8:32 PM
Data refreshes hourly during market hours. Next update: 8:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Gael Touya
SELL
3500 shares
2026-02-18
Daniel Ackerman
SELL
15000 shares
2025-12-12
Michael T. McCaul
BUY
2025-11-19
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$180 | 49 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
Advanced ATR Option Strategies
Professional options setups generated by AI based on today's ATR price and gamma walls.
